Arriel Makembi Bunkete | Health Professions | Best Researcher Award

Published on by TOT Awards

Dr. Arriel Makembi Bunkete | Health Professions | Best Researcher Award

University of Kinshasa | Congo, Democratic Republic of the

Dr. Arriel Makembi Bunkete is a dedicated nephrologist and internal medicine specialist whose clinical and scientific work focuses on kidney transplantation, dialysis innovations, and the epidemiology of chronic kidney disease across diverse and resource-limited settings. He has developed a strong research identity through his contributions to transplant coordination, acute and chronic dialysis strategies, extracorporeal purification techniques, clinical nephrology, glomerular diseases, and the management of toxicological and environmental kidney injuries. His multidisciplinary approach integrates clinical practice, research leadership, and collaborative scientific work with teams in French Guiana, France, and the Democratic Republic of the Congo. Dr. Bunkete’s research addresses critical challenges such as anemia in kidney transplant recipients, sickle cell nephropathy, lupus nephritis activity, paraquat poisoning, high blood lead levels in dialysis patients, and the implementation of home hemodialysis in remote territories. His scientific output includes peer-reviewed articles, case reports, international conference abstracts, and involvement in ongoing epidemiological studies. Recognized for his growing academic influence, he has accumulated 4 citations, an h-index of 1, and an i10-index of 0 (Google Scholar metrics), with comparable citation performance indexed in Scopus. He also contributes as a reviewer for leading nephrology journals, reflecting his commitment to advancing global renal research. His work has received competitive research grant support for studies on APOL1 variants and chronic kidney disease in French Guiana, reinforcing his standing as an emerging investigator in tropical nephrology and transplant medicine. With a strong scientific footprint, ongoing research leadership, and steady scholarly growth, Dr. Bunkete demonstrates the qualities associated with the Best Researcher Award in nephrology.

Publication Profile

Google Scholar

Featured Publications

Bunkete, A. M. (2025). Home hemodialysis in French Guiana: Transforming logistical challenges into healthcare opportunities. Bulletin de la Dialyse à Domicile, 8(2), 107–111.

Kabasele, D. B., Bunkete, A. M., Mbayabo, G., Lumbala, P., Matondo, O., Aloni, M., et al. (2025). Hydroxyurea and regression of sickle cell nephropathy: Open clinical trial in a pediatric population in DR Congo. Kidney360.

Bunkete, A. M., Kasonga, P. K., Fermigier, F., & Djiconkpode, I. (2025). WCN25-137: Pediatric nephrology in French Guiana – Overview and outlook. Kidney International Reports, 10(2), S615.

Anga, K., Makembi, A., Amisi, É., Delpierre, É., Ha, V. H. T., Mbombo, W., et al. (2024). Morbidity and mortality of acute renal failure in COVID-19 patients in intensive care according to waves/variant: Case of the Grand Hôpital de l’Est Francilien site de Meaux. Open Journal of Internal Medicine, 14(1), 16–29.

Bunkete, A. M., Belgrine, M., Sidibe, M., Bellony, S., Davodun, T., Djiconkpode, I., et al. (2025). Dialyse péritonéale chez un nourrisson avec insuffisance rénale aiguë sévère: Dialyse réalisée en plein vol lors d’une évacuation sanitaire en Guyane – À propos d’un cas. Bulletin de la Dialyse à Domicile, 8(3), 255–261.

Liu Wenyi | Health Sciences | Best Researcher Award

Published on by TOT Awards

Dr. Liu Wenyi | Health Sciences | Best Researcher Award

Cancer Hospital Chinese Academy of Medical Sciences | China

Dr. Liu Wenyi is a thoracic-surgery specialist whose research focuses on advanced treatments for thoracic malignancies especially esophageal and lung cancers emphasising organ-preservation strategies, neoadjuvant chemo-/chemo-immunotherapy, imaging- and machine-learning-based response assessment, and translational biomarkers for surgical decision-making. His work has contributed to the evolving paradigm of less-invasive surgery and more personalised multimodal care. For example, his recent narrative review “Organ Preservation in Esophageal Cancer: Current Strategies, Challenges, and Future Directions” is a state-of-the-field synthesis published in Cancers  highlighting novel surveillance-based approaches in esophageal squamous cell carcinoma. His Google Scholar/Scopus profile indicates approximately 10 publications and a current h-index of 5 (citations ~80) under his name. This volume reflects a mid-career emerging investigator whose trajectory is marked by high-impact topics (thoracic oncology, immunotherapy, AI-enabled imaging) and whose top publications already appear in high-visibility journals. Dr. Liu’s work is characterized by integrating minimally invasive surgical techniques, cutting-edge neoadjuvant systemic treatments and advanced predictive modelling to stratify patients for surgical risk and organ-sparing pathways thus contributing to both improved patient quality of life and optimized oncologic outcomes.His outstanding contributions to clinical innovation and scientific research excellence reflect strong merit for recognition under the Best Researcher Award .

Publication Profile

Orcid

Featured Publications

Liu, W., Guo, X., Zhao, H., Yu, X., Wang, C., Du, L., Wang, F., & Mu, J. (2020). Mediastinoscopy-assisted transhiatal esophagectomy versus thoraco-laparoscopic esophagectomy for esophageal cancer: A single-center initial experience. Journal of Thoracic Disease, 12(9), 4908-4914.

Liu, W., Tang, J., Li, X., Gong, L., Yang, D., Yin, H., Wang, W., & Zhang, B. (2025). Reduction in surgical scope after neoadjuvant chemotherapy and immunotherapy for non-small cell lung cancer. Oncology Letters, 30(5), 501.

Liu, W., Sui, Z., Wang, C., Deng, Y., Cai, S., Jia, R., Yu, Z., Kang, M., & Zhang, B. (2025). Nomogram for predicting pathological complete response to neoadjuvant chemoimmunotherapy in patients with resectable non-small cell lung cancer. Frontiers in Cell and Developmental Biology, 13, 1679782.

Hong, Z., Xie, S., Xu, H., Ke, S., Liu, W., Huang, S., Chen, S., Xie, J., Xu, J., & Kang, M. (2025). Major pathologic response as a prognostic surrogate in esophageal squamous cell carcinoma patients receiving neoadjuvant chemotherapy/chemoimmunotherapy: A multi-center cohort study. European Journal of Surgical Oncology, 51(2), 109500.

Liu, W., Zhang, B., Wang, C., Yu, X., Du, L., Yu, Z., & Kang, M. (2025). Organ Preservation in Esophageal Cancer: Current Strategies, Challenges, and Future Directions. Cancers, 17(21), 3559.